[Directions for allogenic stem cell transplants and how they reflect on the operation and results of the transfer center in Turku].
Remes
Kari
K
TYKS:n sisätautien klinikka, Turku. kari.remes@tyks.fi
Luoma
Sini
S
Salmi
Toivo T
TT
Tarja-Terttu
Pelliniemi
P
Itälä
Maija
M
Kauppila
Marjut
M
Nikoskelainen
Jukka
J
Putkonen
Mervi
M
Kairisto
Veli
V
Rajamäki
Allan
A
Tienhaara
Anri
A
Pyrhönen
Seppo
S
Rauhala
Auvo
A
D000046:Academic Medical Centers; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000379:methods; D005260:Female; D005387:Finland; D006084:Graft Rejection; D006085:Graft Survival; D019337:Hematologic Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D018579:Patient Selection; D011379:Prognosis; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000592:standards* / Q000639:trends; D014184:Transplantation, Homologous; D016896:Treatment Outcome